Gujarat Themis (GUJTHEM) | Stock Overview & Key Data
Gujarat Themis Performance Comparison
Stock Range
Today's Range
Low: ₹416.15
High: ₹434.00
on October 6, 2025
52 Week Range
Low: ₹208.00
High: ₹434.00
on March 3, 2025
on October 6, 2025
All-Time High: ₹434.00 on October 6, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR46.2B
EPS
4.10
P/E Ratio (TTM)
103.15
Forward P/E
N/A
P/B Ratio
18.55
PEG Ratio
-3.26
Div. Yield
0.17%
ROE
19.64%
Beta
-0.374
Debt to Equity
12.27
Financial Highlights
Profitability
Gross Margin
77.71%
Operating Margin
33.14%
Profit Margin
30.17%
Returns and Earnings
Return on Assets (TTM)
16.19%
Return on Equity (TTM)
19.64%
EBITDA
INR661.5M
Net Income (TTM)
INR446.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR13.57
Quarterly Revenue Growth (YoY)
-7.60%
Quarterly Earnings Growth (YoY)
-31.50%
Dividend Information
Last 12-Month Dividend
₹0.67
Current Dividend Yield
0.17%
3-Year Average Dividend Yield
0.17%
3-Year Average Annual Dividend
₹0.22
3-Year Total Dividends
₹0.67
Ex-Dividend Date
September 4, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Themis GUJTHEM | 46.19B Small-cap | 5.76% | 7.50% | 23.75% | 49.86% | 73.70% | 93.18% | 93.18% | 93.18% |
| Sun Pharmaceutical SUNPHARMA | 4.01T Large-cap | 2.80% | 3.33% | -2.89% | -7.84% | -13.69% | -14.60% | 70.78% | 218.03% |
| Divi's Laboratories DIVISLAB | 1.61T Large-cap | 3.10% | -4.83% | -14.69% | 1.79% | -3.41% | 8.12% | 57.02% | 83.89% |
| Innova Captab INNOVACAP | 48.64B Small-cap | 0.59% | -7.07% | -0.71% | -5.56% | -23.39% | 15.25% | 57.00% | 57.00% |
| Suven Life Sciences SUVEN | 47.99B Small-cap | -0.20% | -3.13% | -15.86% | 58.76% | 63.09% | 46.77% | 186.97% | 307.88% |
| Aarti Drugs AARTIDRUGS | 44.87B Small-cap | 4.61% | 0.24% | 1.59% | 41.06% | 7.93% | -4.79% | -0.89% | -50.06% |
Ownership & Short Interest
Insider Ownership
70.87%
Institutional Ownership
1.15%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
354K
Average 90-Day Volume
202K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is GUJTHEM's 52-week high and low?
- In the last 52 weeks, Gujarat Themis reached a high of ₹434.00 (on October 6, 2025) and a low of ₹208.00 (on March 3, 2025).
- What is the market cap and P/E ratio for GUJTHEM?
- Curious about Gujarat Themis's size and valuation? Its market capitalization stands at 46.19B. When it comes to valuation, the P/E ratio (trailing twelve months) is 103.15, and the forward P/E (looking ahead) is N/A.
- Does GUJTHEM pay dividends? If so, what's the yield?
- Yes, Gujarat Themis is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.17%, and the company has paid an average of ₹0.22 per share annually over the past 3 years.
- Who are Gujarat Themis's main competitors or similar companies to consider before investing?
When looking at Gujarat Themis, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA4.01T Healthcare Drug Manufacturers - Specialty & Generic -14.60% 70.78% Divi's Laboratories
DIVISLAB1.61T Healthcare Drug Manufacturers - Specialty & Generic 8.12% 57.02% Innova Captab
INNOVACAP48.64B Healthcare Drug Manufacturers - Specialty & Generic 15.25% 57.00% Suven Life Sciences
SUVEN47.99B Healthcare Drug Manufacturers - Specialty & Generic 46.77% 186.97% Aarti Drugs
AARTIDRUGS44.87B Healthcare Drug Manufacturers - Specialty & Generic -4.79% -0.89% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Gujarat Themis Biosyn Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Gujarat Themis's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 19.64%, the Debt to Equity ratio from the most recent quarter is 12.27, and its Gross Profit Margin stands at 77.71%.
- What is the recent revenue and earnings growth for GUJTHEM?
- Looking at Gujarat Themis's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by -7.60%, and quarterly earnings saw a YoY growth of -31.50%.
- How much of GUJTHEM stock is held by insiders and institutions?
- Wondering who owns Gujarat Themis stock? Company insiders (like executives and directors) hold about 70.87% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 1.15%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.